Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

Pfizer will receive around £2.7 billion in aggregate from Haleon from an offering and a share buyback.

With Tuesday’s announcement, Eastern North Carolina adds to its reputation for large-scale pharmaceutical manufacturing, as ...

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

An OPEC+ panel is unlikely this week to recommend any changes to its current deal to reduce production and to start unwinding ...

Pfizer withdrew its sickle cell disease treatment Oxbryta. Meanwhile, Senators introduce new bill to fortify health-care ...

A good chunk of your paycheck goes to medical insurance. Know your options. Prudent action and planning maximize every dollar ...

New data show excellent quality-of-life outcomes and effective tumor control for both intensity-modulated radiation therapy ...

Patients with chronic spontaneous urticaria improved early, with benefits lasting through the 52-week follow-up for those who ...

Pfizer anticipates revenue growth, driven by oncology investments, M&A activities, and manufacturing optimization. See why ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

No large pharma company has traversed this decade's ups and downs quite like Pfizer. | No large pharma company has traversed ...